Doxorubicin Hydrochloride
NDC 68001-492, Doxorubicin Hydrochloride, injectable, liposomal, from BluePoint Laboratories.
- Product NDC
- 68001-492
- Status
- Listed
- Labeler
- BluePoint Laboratories
- Dosage form
- INJECTABLE, LIPOSOMAL
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203263
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-492 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXORUBICIN HYDROCHLORIDE2 mg/mL
Pharmacologic classes
Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-492-36 | 68001049236 | 1 VIAL, SINGLE-DOSE in 1 PACKAGE (68001-492-36) / 10 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f6508535-e7a7-4e50-8d0c-43deda8d0d08Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=68001-492
Use it
Look up 68001-492 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-492 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-492. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.